According to a recent LinkedIn post from Colossal Biosciences, the company is drawing attention to the scientific and physical underpinnings of blue coloration in nature. The post notes that while blue is a highly favored color among humans globally, it is relatively rare in plants and animals, and often arises from structural effects rather than pigments.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights how microscopic structures in animals and complex pigment–light interactions in plants create the perception of blue, framing it as a kind of optical illusion. For investors, this emphasis on the physics and biology of coloration may suggest ongoing efforts by Colossal to engage audiences with fundamental science, potentially supporting brand positioning as a deep-tech, research-driven organization within the synthetic biology and de-extinction space.
While the content does not reference specific products, partnerships, or funding events, the educational focus could help cultivate broader public interest in advanced biological engineering. Over time, such visibility and scientific storytelling may contribute indirectly to talent attraction, stakeholder engagement, and differentiated positioning relative to other life-science and biotech platforms.